SRZNMICRO

Surrozen, Inc.

HealthcareBiotechnology
$30.75
$0.03(-9.90%)
52W$5.90
$35.00
Updated May 8, 12:00 AM
RSI62
RS Rating94/99
Beta0.76
Volatility77%
F-Score3/9
Mkt Cap$230M
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Surrozen, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 94), indicating clear outperformance against the broad market. Earnings contraction of 57% provides fundamental context to the price action. Investors should exercise caution due to high volatility (77% annualized), which requires wider risk management.

Relative Strength
94
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
0.76
vs S&P 500
DEFENSIVE
52W Position
85%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$28.68
50 SMA > 100 SMA$25.41
100 SMA > 150 SMA$21.82
150 SMA > 200 SMA$19.15

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$31.36-1.96%BELOW
50 SMA$28.68+7.21%ABOVE
100 SMA$25.41+21.01%ABOVE
150 SMA$21.82+40.91%ABOVE
200 SMA$19.15+60.57%ABOVE

Price Performance

1D-9.9%
1W-7.9%
1M+19.3%
3M+38.9%
6M+152.0%
YTD+42.7%
1Y+232.4%
3Y+51.3%
52-Week Trading Range85% from low
$30.75
52W Low$5.90
52W High$35.00

Technical Indicators

RSI (14)BULLISH
61.5
305070
VCP ScoreCOOL
2/10
Base depth: 42.2%

Risk Profile

Beta
0.76
52W Vol
77%
ATR
$2.61
Max DD (1Y)
-38%

Volume Analysis

Today
74.4K
50D Avg
109.3K
Vol Ratio
0.68x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+132%
$2.55
Q3'25-1800%
$-8.36
Q4'25-165%
$-23.87
Q1'26-57%
$-11.65
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:-34.72%
TTM:-35.61%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-66.25%

Stock Price CAGR

10 Years:-14.75%
5 Years:-26.94%
3 Years:+51.29%
1 Year:+232.43%

Return on Equity

10Y Avg:-186.2%
5Y Avg:-237.3%
3Y Avg:-421.7%
Last Year:

Key Metrics

Market Cap$230M
Gross Margin84.6%
Net Margin-69.6%
Piotroski F-Score3/9

Frequently Asked Questions

Is SRZN in an uptrend right now?

SRZN has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, SRZN is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is SRZN overbought or oversold?

SRZN's RSI (14) is 62. The stock is in neutral territory, neither overbought nor oversold.

Is SRZN outperforming the market?

SRZN has a Relative Strength (RS) Rating of 94 out of 99. Yes, SRZN is a market leader, outperforming 94% of all stocks over the past 12 months.

Where is SRZN in its 52-week range?

SRZN is trading at $30.75, which is 88% of its 52-week high ($35.00) and 85% above its 52-week low ($5.90).

How volatile is SRZN?

SRZN has a Beta of 0.76 and 52-week volatility of 77%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.